Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 2:11:1371720.
doi: 10.3389/fmed.2024.1371720. eCollection 2024.

Editorial: Community series - liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies, volume II

Ana Sandoval-Rodriguez  1 , Aldo Torre-Delgadillo  2 , Juan Armendariz-Borunda  1   3
Affiliations
Editorial

Editorial: Community series - liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies, volume II

Ana Sandoval-Rodriguez et al. Front Med (Lausanne). .
No abstract available

Keywords: MAFLD; MASLD; liver fibrosis; non-alcoholic steatohepatitis (NASH); steatotic liver disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Community series - liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies, volume II

Similar articles

See all similar articles

References

    1. Sandoval-Rodriguez A, Torre A, Armendariz-Borunda J. Editorial: Liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies. Front Med. (2022) 9:892495. 10.3389/fmed.2022.892495 - DOI - PMC - PubMed
    1. Eslam M, Sanyal AJ, George J, International Consensus Panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. (2020) 158:1999–2014. 10.1053/j.gastro.2019.11.312 - DOI - PubMed
    1. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. . A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. (2023) 79:1542–56. 10.1097/HEP.0000000000000696 - DOI - PubMed
    1. Xiao J, Lim LKE, Ng CH, Tan DJH, Lim WH, Ho CSH, et al. . Is fatty liver associated with depression? A meta-analysis and systematic review on the prevalence, risk factors, and outcomes of depression and non-alcoholic fatty liver disease. Frontiers in medicine. (2021) 8:691696. 10.3389/fmed.2021.691696 - DOI - PMC - PubMed

Publication types

LinkOut - more resources